Background: Endoscopic biopsy of brain tumors is an important part of the armamentarium of management of intra-and periventricular tumors that is generally considered an acceptable and, in some situations, a preferred method for tissue sampling. The diagnostic yield of the procedure has been variably reported.
INTRODUCTION
Fukushima was the first to introduce endoscopic brain biopsy in 1973 using a flexible fiberoptic ventriculofiberscope. [12] Five years later, he reported a series of 21 endoscopic biopsies for intraventricular tumors, of which a correct histopathological diagnosis was achieved in 11 patients. [13] Currently, the procedure is an important part of the armamentarium of management of intra-and periventricular tumors [10, 22, 31, 35, 37, 40, 42, 47, 49, 51] that is generally considered an acceptable and, in some situations, a preferred method for tissue sampling. Notwithstanding this, the diagnostic yield of endoscopic brain tumor biopsy has been variably reported. [2] [3] [4] [5] 7, 9] As technical aspects of the procedure undoubtedly reflect on its success rate and accuracy, a review of the literature was conducted in order to shed light on the technical aspects of endoscopic biopsy of brain tumors as they pertain to the diagnostic yield of the procedure.
MATERIALS AND METHODS
A search of the English literature was conducted and 43 reports were retrieved from 1990 to July 2013 [ Table 1 ].
The following technical aspects were evaluated in each study: Type of endoscopes used, use of stereotactic guidance, and histopathological methods utilized for diagnosis.
Regarding the type of endoscopes used, the published studies were subdivided into four groups according to the use of lenscopes versus fiberscopes [ Tables 1 and 2 ]. These four groups included: (1) Lenscopes only, (2) fiberscopes only, (3) mixed group, where both types were used without specification of the diagnostic yield for either type, and (4) unspecified group, where the type of endoscope was not reported by the authors. The diagnostic yield in each group was then calculated as the percentage of biopsies leading to a histological diagnosis to the total number of biopsies performed. When both types of endoscopes were used in one report, results were considered to belong to either the lenscopes or the fiberscope group only if the authors specified the diagnostic yield according to the type of the endoscope used. Unfortunately, a specific diagnostic yield based on the type of endoscopic device was rarely reported in these mixed studies. [15, 17, 29, 34, 36] 
RESULTS
The results of the study are presented in Tables 1-3 and Figure 1 .
In the 43 reports analyzed, lenscopes were exclusively used in 22 reports and a tissue diagnosis was possible in 362 out of 387 endoscopic biopsies with a diagnostic yield of 93.54%. Only fiberscopes were used in 8 reports and a tissue diagnosis was possible in 100 out of 132 endoscopic biopsies with a diagnostic yield of 75.76%. The diagnostic yield in the mixed and unspecified groups was 88.95 and 88.04%, respectively [ Table 2 and Figure 1 ].
DISCUSSION
Endoscopic biopsy of brain tumors is currently regarded an effective tool that is sometimes indispensable in establishing tissue diagnosis and tailoring further treatment [ Figures 2-4 ]. [1, 15, 23, 26, 28, 45] Using the procedure for lesions within the ventricular system or in its vicinity offers direct visualization of the intraventricular anatomy and enables precise sampling of areas of the lesion that are highly likely to be pathologically representative, a feature that has been found to improve diagnostic accuracy. Additionally, biopsies from areas with an overlying blood vessel can be avoided, and areas with high vascularity can be coagulated to reduce bleeding during the procedure. [25] The literature is currently replete with reports of endoscopic brain biopsies in which success rates range from as low as 61% up to 100%. [2] [3] [4] 7, 9, 14, 19, 20, 23, 26, 33, 41, 43, 48, 50] Analysis of the published reports retrieved a total of 1927 endoscopic brain biopsies in which the procedure led to a diagnostic information in 1735 cases, a collective diagnostic yield of 90.04% [ Table 2 ]. In 2008, Fiorindi and Longatti calculated a collective success rate of 88% in 206 endoscopic brain biopsies compiled from eight published series. [11] In the largest two series published so far, Constantini et al. [5] reported diagnostic yield of 90.4% in 691 biopsies and Hayashi et al. [15] reported a diagnostic yield of 89.7% in 293 procedures.
From the technical point of view, one of the drawbacks inherent to neuroendoscopes of today's technology is their narrow working channels which may compromise the size of tissues retrieved and result in pathological interpretation challenges due to small fragmented or inadequate samples. [5, 16] In one series of 31 patients from the Hospital for Sick Children, Toronto, Depreitere et al. [6] reported the small size of the biopsy samples as the primary reason for failure and problematic histological interpretation in 5 cases. The diagnostic yield of endoscopic biopsy was noted to increase when lenscopes were used instead of fiberscopes. [1, 6] Lenscopes allow using larger-diameter biopsy forceps and, therefore, obtaining larger tumor samples. Moreover, they offer higher quality endoscopic images which enable obtaining samples from various regions of the exposed tumor surface. [4, 24, 25, 39] Notably, however, no prospective assessment of the comparative diagnostic yields of lenscopes versus fiberscope endoscopic brain tumor biopsy has been carried out yet. Based on our analysis of the literature, a conclusion in favor of using a lenscope to obtain biopsy of brain tumors can clearly be drawn. Similar to our results, Mohanty et al. noted a correlation between the use of a fiberscope and a relatively higher nondiagnostic biopsy versus higher success rates being uniformly demonstrated with the use of lenscope endoscopes. [25] It is of note that in the majority of reports, the authors have not specified the number of samples taken from the tumor. Some have pointed out that the number of samples was governed by intraoperative pathological interpretation with no more tissue than absolutely necessary taken in order to reduce intraventricular hemorrhage. [26] Others have reported two or more, [50] a minimum of three, [20] or just multiple specimens [28] during the biopsy procedure.
The reason for a preference to use a lenscope versus a fiberscope was also infrequently clarified in many articles reviewed. Superior image resolution [38, 46] and larger working channels were stated by some authors using lenscopes, [4, 26, 46] while in some reports where fiberscopes were used, the justification was the possibility of safely reaching the posterior third ventricle. [3, 44] It was evident from literature analysis that using stereotactic guidance resulted in higher chances of obtaining a pathologically diagnostic material. The success rate for neuronavigation-guided endoscopic biopsy was 98% versus 92.67% when lenscopes were used alone. It is of note that although intraventricular anatomical structures would normally serve as the anatomical landmarks which give the neurosurgeon a spatial orientation, navigated endoscopy would be very important in cases with small or distorted ventricles, posterior third ventricular and periventricular tumors. [46] Although the objective of this review was not to investigate all variables related to the diagnostic accuracy of endoscopic brain biopsy, it is important to point out that tumor location seems to play a role in the success rate of the biopsy. Ahn and Goumnerova reported success rates of 100%, 87.5%, 57%, and 25% for lateral ventricular, pineal region, thalamic, and tectal plate lesions, respectively. [1] High failure rates for superior vermian biopsies [25] and posterior fossa tumors [6] have also been reported. Such suboptimal success rates can probably be ascribed to difficulty of access to some areas. [25] More importantly, the pathological approach to endoscopic brain tumor biopsy has not previously been detailed. [16] In none of the studies did the authors refer to uncertainties expressed by the pathologist regarding the final diagnosis, which may partly explain the variations in biopsy success rates. [6] Upon reviewing the literature, it was noticed that the histopathological diagnostic methods are seldom discussed and always overlooked, especially with respect to the molecular and immunohistochemical features of brain tumors. Except for one study by Husain et al. [16] published in 2010, only very few studies with scarce information [2, 9, 29] or single case reports [27] are available.
Molecular subtyping of brain tumors is becoming increasingly recognized as a valuable tool with diagnostic, prognostic, and therapeutic significance. For instance, the inactivating abnormalities of hSNF5/INI1/ SMARCB1/BAF47 tumor suppressor gene on chromosome 22q11.2 allowed segregating atypical teratoid rhabdoid tumors (ATRTs) from potential mimickers, [8, 30] and the fusion between KIAA1549 and BRAF oncogene specific to pilocytic astrocytomas is becoming an area for potential novel treatments. [18] To date, almost all assessments of successful endoscopic biopsy have been based upon conventional histopathological criteria. [5, 15, 17, 21] To the best of our knowledge, only one report [16] on endoscopic biopsy of brain tumors has documented the immunohistochemical characteristics and in none of the studies have the molecular subtypes of tumors been reported. As some of these advanced pathology assays are dependent to a degree on the volume of tissue and the method of tissue processing, the technique of sampling and the equipment utilized may have an impact on the ability to obtain such increasingly important pathologic information. Prospective studies comparing the different contemporary endoscopic techniques as they relate to the molecular subtyping of brain tumors may help guide the surgeons' selection of biopsy technique.
CONCLUSION
Endoscopic biopsy of brain tumors has a higher diagnostic yield when lenscopes are used. Neuronavigation seems to add to the diagnostic accuracy of the procedure. Studies detailing molecular genetic features of biopsied tumors are necessary in the future.
